Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2052-3211
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan ; volume:15 ; number:1 ; day:24 ; month:2 ; year:2022 ; pages:1-6 ; date:12.2022
Journal of pharmaceutical policy and practice ; 15, Heft 1 (24.2.2022), 1-6, 12.2022
- Classification
-
Wirtschaft
- Creator
-
Babar, Zaheer-Ud-Din
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40545-022-00413-3
- URN
-
urn:nbn:de:101:1-2022052619364685594147
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Babar, Zaheer-Ud-Din
- SpringerLink (Online service)
Other Objects (12)
A Framework for the Fair Pricing of Medicines
Application of four pricing models for orphan medicines: a case study for lumasiran
Medicines patents, access and innovation : the growing challenges for people in low and middle-income countries to access new medicines
Price tagging the priceless: International reference pricing for medicines in theory and practice
Future information technology tools for fighting substandard and falsified medicines in low- and middle-income countries
Understanding the trends in international agreements on pricing and reimbursement for newly marketed medicines and their implications for access to medicines: a computational text analysis
Health policy and systems research in access to medicines: a prioritized agenda for low- and middle-income countries
Organizing for Pricing
Access to cardiovascular medicines in low- and middle-income countries: a mini review
Distributional Impacts of Carbon Pricing in Low- and Middle-Income Countries
Approval, reimbursement and pricing of high-cost cancer medicines in Australia
Implementation of medicines pricing policies in sub-Saharan Africa: systematic review
A Framework for the Fair Pricing of Medicines
Application of four pricing models for orphan medicines: a case study for lumasiran
Medicines patents, access and innovation : the growing challenges for people in low and middle-income countries to access new medicines
Price tagging the priceless: International reference pricing for medicines in theory and practice
Future information technology tools for fighting substandard and falsified medicines in low- and middle-income countries
Understanding the trends in international agreements on pricing and reimbursement for newly marketed medicines and their implications for access to medicines: a computational text analysis
Health policy and systems research in access to medicines: a prioritized agenda for low- and middle-income countries
Organizing for Pricing
Access to cardiovascular medicines in low- and middle-income countries: a mini review
Distributional Impacts of Carbon Pricing in Low- and Middle-Income Countries
Approval, reimbursement and pricing of high-cost cancer medicines in Australia
Implementation of medicines pricing policies in sub-Saharan Africa: systematic review
A Framework for the Fair Pricing of Medicines
Application of four pricing models for orphan medicines: a case study for lumasiran
Medicines patents, access and innovation : the growing challenges for people in low and middle-income countries to access new medicines
Price tagging the priceless: International reference pricing for medicines in theory and practice
Future information technology tools for fighting substandard and falsified medicines in low- and middle-income countries
Understanding the trends in international agreements on pricing and reimbursement for newly marketed medicines and their implications for access to medicines: a computational text analysis
Health policy and systems research in access to medicines: a prioritized agenda for low- and middle-income countries
Organizing for Pricing
Access to cardiovascular medicines in low- and middle-income countries: a mini review
Distributional Impacts of Carbon Pricing in Low- and Middle-Income Countries
Approval, reimbursement and pricing of high-cost cancer medicines in Australia